Related references
Note: Only part of the references are listed.Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants
Bethany T. Samuelson et al.
CHEST (2017)
Reversing Dabigatran Anticoagulation with Prothrombin Complex Concentrate versus Idarucizumab as Part of Multimodal Hemostatic Intervention in an Animal Model of Polytrauma
Markus Honickel et al.
ANESTHESIOLOGY (2017)
Peri-operative management of anticoagulation and antiplatelet therapy
David Keeling et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration
Bryan D. Hayes et al.
CLINICAL TOXICOLOGY (2016)
Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning
Sophie Gosselin et al.
CLINICAL TOXICOLOGY (2016)
Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity
Michael Levine et al.
CLINICAL TOXICOLOGY (2016)
When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
J. H. Levy et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Methodology for AACT evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning
Sophie Gosselin et al.
CLINICAL TOXICOLOGY (2015)
Idarucizumab for Dabigatran Reversal
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
Tomas L. Lindahl et al.
THROMBOSIS RESEARCH (2015)
On the monitoring of dabigatran treatment in real life patients with atrial fibrillation
Mika Skeppholm et al.
THROMBOSIS RESEARCH (2014)
Asystole Immediately Following Intravenous Fat Emulsion for Overdose
Jon B. Cole et al.
JOURNAL OF MEDICAL TOXICOLOGY (2014)
Complications Following Antidotal Use of Intravenous Lipid Emulsion Therapy
Michael Levine et al.
JOURNAL OF MEDICAL TOXICOLOGY (2014)
Intravenous Lipid Emulsion Does Not Reverse Dabigatran-induced Anticoagulation in a Rat Model
Jared Blum et al.
ACADEMIC EMERGENCY MEDICINE (2013)
Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
T. Baglin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Clinical Experience with Intravenous Lipid Emulsion for Drug-Induced Cardiovascular Collapse
Ann-Jeannette Geib et al.
JOURNAL OF MEDICAL TOXICOLOGY (2012)
Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation
Stephen D. Bendel et al.
ADVANCES IN THERAPY (2011)
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial
John W. Eikelboom et al.
CIRCULATION (2011)
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
Tomas L. Lindahl et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Cardiotoxic Overdose Treated with Intravenous Fat Emulsion and High-Dose Insulin in the Setting of Hypertrophic Cardiomyopathy
Samuel J. Stellpflug et al.
JOURNAL OF MEDICAL TOXICOLOGY (2011)
Lipid emulsions in the treatment of acute poisoning: a systematic review of human and animal studies
Chloe Jamaty et al.
CLINICAL TOXICOLOGY (2010)
Intentional overdose with cardiac arrest treated with intravenous fat emulsion and high-dose insulin
Samuel J. Stellpflug et al.
CLINICAL TOXICOLOGY (2010)
Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
Joanne van Ryn et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Intravenous Lipid Emulsion as Antidote Beyond Local Anesthetic Toxicity: A Systematic Review
Grant Cave et al.
ACADEMIC EMERGENCY MEDICINE (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
Sam Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Adsorption of Dabigatran Etexilate in Water or Dabigatran in Pooled Human Plasma by Activated Charcoal in Vitro.
Joanne van Ryn et al.
BLOOD (2009)
Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate
Joachim Stangier
CLINICAL PHARMACOKINETICS (2008)
Dabigatran with or without concomitant Aspirin compared with Warfarin alone in patients with nonvalvular atrial fibrillation (PETRO study)
Michael D. Ezekowitz et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity
G Weinberg et al.
REGIONAL ANESTHESIA AND PAIN MEDICINE (2003)
The ecarin clotting time, a universal method to quantify direct thrombin inhibitors
G Nowak
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
